Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA.
Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, 48109, USA.
Breast Cancer Res. 2020 Jun 3;22(1):59. doi: 10.1186/s13058-020-01298-3.
Breast cancer is a heterogeneous disease. Hence, stratification of patients based on the subtype of breast cancer is key to its successful treatment. Among all the breast cancer subtypes, basal-like breast cancer is the most aggressive subtype with limited treatment options. Interestingly, we found focal adhesion kinase (FAK), a cytoplasmic tyrosine kinase, is highly overexpressed and activated in basal-like breast cancer.
To understand the role of FAK in this subtype, we generated mice with conditional deletion of FAK and a knock-in mutation in its kinase domain in MMTV-Wnt1-driven basal-like mammary tumors. Tumor initiation, growth, and metastasis were characterized for these mice cohorts. Immunohistochemical and transcriptomic analysis of Wnt1-driven tumors were also performed to elucidate the mechanisms underlying FAK-dependent phenotypes. Pharmacological inhibition of FAK and mTOR in human basal-like breast cancer cell lines was also tested.
We found that in the absence of FAK or its kinase function, growth and metastasis of the tumors were significantly suppressed. Furthermore, immunohistochemical analyses of cleaved caspase 3 revealed that loss of FAK results in increased tumor cell apoptosis. To further investigate the mechanism by which FAK regulates survival of the Wnt1-driven tumor cells, we prepared an isogenic pair of mammary tumor cells with and without FAK and found that FAK ablation increased their sensitivity to ER stress-induced cell death, as well as reduced tumor cell migration and tumor sphere formation. Comparative transcriptomic profiling of the pair of tumor cells and gene set enrichment analysis suggested mTOR pathway to be downregulated upon loss of FAK. Immunoblot analyses further confirmed that absence of FAK results in reduction of AKT and downstream mTOR pathways. We also found that inhibition of FAK and mTOR pathways both induces apoptosis, indicating the importance of these pathways in regulating cell survival.
In summary, our studies show that in a basal-like tumor model, FAK is required for survival of the tumor cells and can serve as a potential therapeutic target.
乳腺癌是一种异质性疾病。因此,基于乳腺癌亚型对患者进行分层是成功治疗的关键。在所有乳腺癌亚型中,基底样乳腺癌是侵袭性最强的亚型,治疗选择有限。有趣的是,我们发现粘着斑激酶(FAK),一种细胞质酪氨酸激酶,在基底样乳腺癌中高度过表达和激活。
为了了解 FAK 在这种亚型中的作用,我们在 MMTV-Wnt1 驱动的基底样乳腺肿瘤中生成了条件性缺失 FAK 和其激酶结构域点突变的小鼠。对这些小鼠队列的肿瘤起始、生长和转移进行了特征描述。还对 Wnt1 驱动的肿瘤进行了免疫组织化学和转录组分析,以阐明 FAK 依赖性表型的机制。还测试了在人基底样乳腺癌细胞系中抑制 FAK 和 mTOR 的药理学作用。
我们发现,在缺乏 FAK 或其激酶功能的情况下,肿瘤的生长和转移明显受到抑制。此外,用 cleaved caspase 3 进行的免疫组织化学分析表明,FAK 的缺失导致肿瘤细胞凋亡增加。为了进一步研究 FAK 调节 Wnt1 驱动的肿瘤细胞存活的机制,我们制备了一对具有和不具有 FAK 的乳腺肿瘤细胞的同基因系,发现 FAK 缺失增加了它们对 ER 应激诱导的细胞死亡的敏感性,以及降低了肿瘤细胞迁移和肿瘤球体形成。对这对肿瘤细胞的比较转录组谱分析和基因集富集分析表明,FAK 缺失导致 mTOR 通路下调。免疫印迹分析进一步证实,FAK 的缺失导致 AKT 和下游 mTOR 通路的减少。我们还发现,抑制 FAK 和 mTOR 通路都能诱导细胞凋亡,表明这些通路在调节细胞存活方面的重要性。
总之,我们的研究表明,在基底样肿瘤模型中,FAK 是肿瘤细胞存活所必需的,可作为潜在的治疗靶点。